EUROAPI Hungary Ltd.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Lessors of Real Property, Not Elsewhere Classified, Land Subdividers and Developers, Except Cemeteries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about EUROAPI Hungary Ltd.
Live alerts from global media, monitored by Business Radar
2025-04-04 (lequotidiendupharmacien.fr)
Customs duties: What consequences for pharmaceutical products in the United States? | The daily life of the pharmacist
Emmanuel Macron brought together on April 3 the main sectors of the French economy including those of the drug and the medical device. Objective: mobilize the sectors in the same direction in reaction to new customs duties announced by Donald Trump. The latter decided to impose 20% of so -called "reciprocal" customs tariffs on European imports, from April 5 and 9. What about the pharmacy sector? What customs taxes for drugs?
Read more